Abstract
1. Following the recent proposal that the selective agonist septide, ([pGlu6,Pro9]SP(6-11)), acts on a novel tachykinin receptor distinct from the 'classical' NK1 receptor, the aim of the study was to investigate the possible heterogeneity of tachykinin NK1 receptors in the rat urinary bladder. 2. The synthetic tachykinin receptor agonists, septide (pD2 7.87) and [Sar9]substance P (SP) sulphone (pD2 7.64) produced concentration-dependent contractions of the rat isolated urinary bladder. 3. The NK1 receptor antagonists GR82,334, (+/-)-CP96,345, and RP67,580 competitively antagonized (slopes of Schild plot not significantly different from unity) the response to septide with the rank order of potency (pKB values in parentheses): RP 67,580 (7.57) > GR 82,334 (7.01) > (+/-)-CP 96,345 (6.80). The same antagonists were significantly less potent when tested against [Sar9]SP sulphone, while maintaining the same rank order of potency: RP 67,580 (7.00) > GR 82,334 (5.93) > (+/-)-CP 96,345 (< 6). The antagonists did not affect the concentration-response curve to bombesin. 4. To exclude the involvement of the NK2 receptor, a second series of experiments was performed in the presence of the potent nonpeptide NK2 receptor antagonist, SR 48,96...Continue Reading
References
Dec 1, 1992·Biochemistry·T M FongC D Strader
Nov 1, 1992·British Journal of Pharmacology·J M HallI K Morton
Jan 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·P L van GiersbergenS H Buck
Jan 1, 1992·Life Sciences·X Emonds-AltJ C Brelière
May 15, 1992·Biochemical and Biophysical Research Communications·C AdvenierD Regoli
Aug 1, 1992·Journal of Autonomic Pharmacology·C A MaggiS Giuliani
Apr 29, 1992·European Journal of Pharmacology·R PatacchiniC A Maggi
Mar 1, 1992·Peptides·F PetitetJ C Beaujouan
Jul 1, 1990·Journal of Medicinal Chemistry·P WardJ R Brown
Jan 25, 1991·Science·R M SniderR W Spencer
Feb 1, 1991·British Journal of Pharmacology·J M Hall, I K Morton
May 17, 1991·European Journal of Pharmacology·C A MaggiP Santicioli
May 17, 1991·European Journal of Pharmacology·B D GitterJ J Howbert
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C GarretP M Laduron
Sep 27, 1991·Brain Research·C TousignantD Regoli
Feb 1, 1991·Trends in Pharmacological Sciences·D H Jenkinson
Nov 4, 1986·European Journal of Pharmacology·C M LeeL L Iversen
Jul 1, 1986·Journal of Medicinal Chemistry·R LauferZ Selinger
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·Y Takeda, J E Krause
Feb 28, 1989·European Journal of Pharmacology·Y Takeda, J E Krause
Nov 16, 1987·Life Sciences·S DionD Regoli
Sep 9, 1986·European Journal of Pharmacology·E Burcher, S H Buck
Jan 1, 1993·British Journal of Pharmacology·A J Barr, S P Watson
Jan 1, 1993·Journal of Neurochemistry·R KageN D Boyd
Jan 22, 1993·Regulatory Peptides·N P GerardC Gerard
Mar 30, 1993·European Journal of Pharmacology·C A MaggiA Giachetti
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Citations
Nov 30, 1993·European Journal of Pharmacology·G R SeabrookJ Longmore
Dec 27, 1995·European Journal of Pharmacology·A B HawcockR M Hagan
Feb 1, 1994·Neuropharmacology·M JungJ C Brelière
Jan 1, 1995·Peptides·Y TorrensJ Glowinski
Jan 1, 1995·Peptides·X L ZhangP J Barnes
Apr 25, 1994·Neuroscience Letters·C PalmaS Manzini
Sep 1, 1995·General Pharmacology·C A Maggi
Aug 1, 1996·Neuroscience·C GauchyM L Kemel
Jan 29, 1997·European Journal of Pharmacology·J C BeaujouanJ Glowinski
Nov 14, 1997·Trends in Pharmacological Sciences·C A Maggi, T W Schwartz
Dec 5, 2000·Regulatory Peptides·V C HoodB L Kidd
Sep 16, 2003·Regulatory Peptides·Angela DjananiChristian J Wiedermann
Dec 28, 1999·Peptides·J C BeaujouanJ Glowinski
May 30, 2001·The International Journal of Biochemistry & Cell Biology·S Harrison, P Geppetti
Jun 1, 1997·British Journal of Pharmacology·M FiginiP Geppetti
Dec 24, 1997·British Journal of Pharmacology·K A Maubach, R S Jones
Mar 7, 1998·British Journal of Pharmacology·J MagranerM L Candenas
Oct 24, 1998·British Journal of Pharmacology·A CiucciT M Werge
Jan 12, 2002·British Journal of Pharmacology·Francesca BellucciCarlo Alberto Maggi
May 1, 1994·British Journal of Pharmacology·C A MaggiA Giachetti
Aug 1, 1994·British Journal of Pharmacology·S Meini, C A Maggi
Apr 1, 1994·British Journal of Pharmacology·A AhluwaliaS Giuliani
Oct 1, 1994·British Journal of Pharmacology·M Malcangio, N G Bowery
Mar 1, 1996·British Journal of Pharmacology·M FiginiP Geppetti
Aug 27, 2011·Experimental Neurology·D E ArtimW C de Groat
Mar 21, 2009·Biochimie·Lei WangChris Shaw
Mar 31, 2004·British Journal of Pharmacology·Riccardo PatacchiniCarlo Alberto Maggi
Sep 27, 2003·Journal of Neurochemistry·Marie-Louise KemelJacques Glowinski
Dec 17, 2009·The American Journal of Pathology·Veronica Sanchez FreireKatia Monastyrskaya
Dec 14, 2004·Life Sciences·Luz CandenasJocelyn N Pennefather
Feb 1, 1995·Neuropeptides·S MeiniC A Maggi
Jun 1, 1997·Neuropeptides·Y TorrensJ C Beaujouan
May 12, 2004·Peptides·Jean-Claude BeaujouanJacques Glowinski
Jul 27, 2005·Peptides·Nigel M Page
Oct 25, 2016·Experimental Neurology·Beatrice GirardMargaret A Vizzard
Dec 16, 1996·FEBS Letters·H Hastrup, T W Schwartz
Mar 1, 2010·Current Protocols in Pharmacology·Stefania Meini, Carlo Alberto Maggi
May 25, 2002·Canadian Journal of Physiology and Pharmacology·A H M CardozoJ B Calixto
Sep 12, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jaimie D NathanRodger A Liddle
Aug 11, 2000·Journal of Neurochemistry·J C BeaujouanJ Glowinski